agilon health (NYSE:AGL) Price Target Lowered to $1.75 at Citigroup

agilon health (NYSE:AGL) had its target price cut by Citigroup from $2.50 to $1.75 in a research report released on Wednesday morning,Benzinga reports. They currently have a sell rating on the stock.

Several other research firms also recently commented on AGL. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a report on Wednesday, October 2nd. TD Cowen cut their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Barclays dropped their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Finally, Stifel Nicolaus reduced their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $6.38.

agilon health Stock Performance

Shares of AGL opened at $1.58 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a 50-day moving average of $3.05 and a two-hundred day moving average of $4.85. The stock has a market cap of $650.99 million, a P/E ratio of -1.68 and a beta of 0.60. agilon health has a one year low of $1.58 and a one year high of $13.76.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the firm earned ($0.06) EPS. As a group, research analysts predict that agilon health will post -0.43 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the last quarter. Capital International Investors boosted its stake in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. State Street Corp boosted its stake in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares in the last quarter. Finally, Citigroup Inc. raised its position in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.